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Insults to the brain that are sub-threshold for damage activate endogenous protective
pathways, which can temporarily protect the brain against a subsequent harmful episode.
This mechanism has been named as tolerance and its protective effects have been
shown in experimental models of ischemia and epilepsy. The preconditioning-stimulus
can be a short period of ischemia or mild seizures induced by low doses of convulsant
drugs. Gene-array profiling has shown that both ischemic and epileptic tolerance feature
large-scale gene down-regulation but the mechanism are unknown. MicroRNAs are a
class of small non-coding RNAs of ∼20–22 nucleotides length which regulate gene
expression at a post-transcriptional level via mRNA degradation or inhibition of protein
translation. MicroRNAs have been shown to be regulated after non-harmful and harmful
stimuli in the brain and to contribute to neuroprotective mechanisms. This review focuses
on the role of microRNAs in the development of tolerance following ischemic or epileptic
preconditioning.
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Preconditioning
The concept of preconditioning was first described in a model of heart ischemia. Here, brief
ischemic episodes protected against a subsequent ischemic insult (Murry et al., 1986), opening
a new way for the treatment of heart diseases. Several preconditioned treatment paradigms have
been used in the clinic (including remote preconditioning stimulus) to protect patients against an
ischemic insult in heart pathologies (McCafferty et al., 2014).
Preconditioning is an adaptive response where a small dose of a harmful substance protects the
brain from a subsequent damaging insult (Murry et al., 1986; Stenzel-Poore et al., 2007; Lin et al.,
2008; Dirnagl et al., 2009; Assaf et al., 2011). The fact that any injury to the brain applied below the
threshold of cell damage, including seizures, will induce preconditioning and neuroprotection to
the brain shows the importance of understanding the mechanism underlying preconditioning and
its potential as novel treatment option in brain disorders.
The preconditioning stimulus induces a transient state of protection which is called tolerance.
Early work demonstrated that de novo protein synthesis was required for tolerance; this implied
regulation of gene expression in a time-specific manner and having an effect only several days after
the precondition stimulus (Barone et al., 1998).
Preconditioning can induce neuroprotection over two time-frames: (1) Rapid tolerance, which
happens in a short period of time and is independent of protein production and is associated
with synapse remodeling (Meller et al., 2008). (2) Delayed (classical) tolerance, which evolves over
1–3 days post-preconditioning and requires de novo protein production which peaks after 3 days
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and diminishes over the course of the following week (Stenzel-
Poore et al., 2007).
Preconditioning Stimuli
Preconditioning can be induced by several stimuli in the brain,
including non-injurious ischemia, cortical spreading depres-
sion, brief episodes of seizures and low doses of endotoxins
(LPS, lipopolysaccharide) (Kitagawa et al., 1990; Simon et al.,
1993; Kobayashi et al., 1995; Chen and Simon, 1997; Towfighi
et al., 1999). A cross-tolerance phenomenon has been recog-
nized where stimuli and challenge are from different nature. For
example, a brief-seizure stimulation or LPS injection can protect
against a subsequent ischemic injury (Plamondon et al., 1999;
Towfighi et al., 1999).
Data has shown that the reprogramming of genes involved
in cellular response to excitotoxic insults plays an important
role in the preconditioning process of different tissues (Mirrione
et al., 2010). Evidence from genomic studies has demonstrated
that diverse stimuli which trigger neuroprotection achieved by
preconditioning may share a common process which depends
on a fundamental reprogramming of the response to injury,
e.g., in ischemia or epileptic tolerance has been shown that
80% of genes are down-regulated. This reprogramming process
can induce novel neuroprotective pathways which in turn lead
to the synthesis of new proteins changing the molecular and
genetic response to subsequent injury (Stenzel-Poore et al., 2004,
2007).
In experimental models of status epilepticus, several precondi-
tioning stimuli including bicuculline, electroshock, kindling, and
low dose injection of the convulsant kainic acid, has shown to
reduce brain damage after status epilepticus (Amini et al., 2014).
Gene profiling has shown that down-regulation of gene expres-
sion is a general mechanism underlying the tolerance process
(Borges et al., 2007; Jimenez-Mateos et al., 2008; Meller et al.,
2008; Della-Morte et al., 2012), including downregulation of
genes involved in ion channels, calcium signaling and excitability
(Jimenez-Mateos et al., 2008).
microRNAs
The term MicroRNA, previously called small temporal RNAs
(stRNAs) due to their role in the regulation of developmental
timing of Caernohabditis elegans, was first introduced in 2001
(Lagos-Quintana et al., 2001; Lau et al., 2001; Lee and Ambros,
2001). Originally microRNAs were defined as small non-coding
RNAs (∼20–22 nucleotides) that regulate post-transcriptional
gene expression in a sequence-specific manner. Since their dis-
covery in C. elegans, microRNAs were found to be expressed in
invertebrates and vertebrates, including humans, and many show
highly-conservation during evolution (Lagos-Quintana et al.,
2001).
MiRNAs regulate gene expression via translational inhibi-
tion, mRNA degradation or a combination of both mechanisms
(O’Carroll and Schaefer, 2013). In the brain, however, miRNA
targeting is frequently not associated with reduced mRNA lev-
els of targets (Klein et al., 2007). Almost 50% of all identified
miRNAs are expressed in the mammalian brain and there is
significant cell- and region-specific distribution reflecting roles
in gene expression that direct the functional specialization of
neurons and the morphological responses that are required to
adapt to their continuously changing activity state (Siegel et al.,
2011; O’Carroll and Schaefer, 2013). MiRNAs and their bio-
genesis components display select localization within neurons,
with significant enrichment in dendrites, enabling local, activity-
dependent miRNA regulation of protein levels (Lugli et al., 2005,
2008; O’Carroll and Schaefer, 2013). Recent work demonstrated
that certain pre-miRs have localization signals which translocate
them to the synaptic sites where they are processed into mature
miRNA (Bicker et al., 2013).
Most miRNA genes are expressed as a cluster within a sin-
gle poly-cistronic transcript (Baskerville and Bartel, 2005) and
transcribed by RNA polymerase II, resulting in the primary
sequence (Cai et al., 2004; Lee et al., 2004). In the nucleus the
primary sequence is recognized by the nuclear microprocessor
complex containing Drosha and DGCR8 (DiGeorge syndrome
critical region 8) which generate the precursor-miRNA (pre-miR)
of ∼60–70 nt length (Lee et al., 2003). Next, the precursor is
exported into the cytoplasm by Exportin-5 in a GTP-dependent
manner (Bohnsack et al., 2004). Once in the cytoplasm, microR-
NAs are further processed by Dicer to a single-strand RNA
mature form (Lagos-Quintana et al., 2001; Lau et al., 2001; Lee
and Ambros, 2001). Finally, a single strand of the mature miRNA
is selected and loaded into the RISC complex and bound to the
members of the Argonaute (Ago) protein family. This miRNA-
bound-RISC complex is the functional and active form of the
miRNA which then targets the mRNA. Binding of a 7–8 nt seed
region, usually within the 3′UTR of the mRNA, results in either
inhibition of the translation or mRNA degradation. This pro-
cess requires the activation of de-cap enzymes and removal of the
poly-A tail (Kwak and Tomari, 2012).
Several studies have shown the role of miRNAs in the brain
by using mainly genetic tools in mice, including conditional or
full deletion of biogenesis enzymes in the microRNA pathway.
Deletion of DGCR8, which affects the production of the precur-
sor microRNA, results in a reduction in brain size and loss of
inhibitory synaptic neurotransmission (Babiarz et al., 2011; Hsu
et al., 2012). Conditional deletion of Drosha in neural progeni-
tors did not affect neurogenesis in the developing brain, but did
affect differentiation and migration of neurons (Knuckles et al.,
2012). Deletion of Dicer from neurons produces severe brain
abnormalities, including microencephaly and defects in dendritic
arborization in cortex and hippocampus (Davis et al., 2008; De
Pietri Tonelli et al., 2008; Babiarz et al., 2011; Dorval et al., 2012).
Mice lacking Dicer in astrocytes develop spontaneous seizures
and suffer from increased premature mortality (Tao et al., 2011).
These data imply that the miRNA biogenesis system is essen-
tial for brain development and function. Surprisingly, one study
reported that specific deletion of Dicer in the adult mouse fore-
brain transiently enhanced learning and memory, although these
animals later displayed degeneration of neurons in the cortex and
hippocampus (Konopka et al., 2010).
Analysis of Argonaute (Ago1–4) proteins, main components
of the RISC complex, has given more diverse results (Burroughs
et al., 2011). Ago-2 is the most abundant expressed member in
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various tissues including the brain (Liu et al., 2004) and critical
for miRNA-mediated repression of mRNAs (Czech and Han-
non, 2011). Deficiency in Ago-2 results in death of mice during
early embryogenesis or mid-gestation (Morita et al., 2007). This
reflects not only the essential role of Ago2 in embryonic devel-
opment but perhaps an effect of impaired microRNA generation
(Morita et al., 2007). In contrast, studies in conditional mutants
showed individual deficiencies in Ago 1, 3, and 4 does not pro-
duce obvious effects in mice, suggesting a redundancy among
Ago family members (O’Carroll et al., 2007).
microRNA in Ischemia Preconditioning
Three different publications show the regulation of microRNAs
after an ischemic preconditioning stimulus in parallel (Table 1)
(Dharap and Vemuganti, 2010; Lee et al., 2010; Lusardi et al.,
2010).
Lusardi et al., using a brief ischemic stimulus in mice, showed
that preconditioning at the same time up-regulated and down-
regulated different microRNAs in the mouse cortex (Lusardi
et al., 2010). A common target-gene of the down-regulated
microRNAs was the transcriptional regulator MeCP2 (methyl
CpG binding protein 2) (Lusardi et al., 2010). Similar results
were found when hypertension was used as preconditioning
stimulus in rats, where multiple down-regulated microRNAs tar-
get MeCP2 (Dharap and Vemuganti, 2010). MeCP2 was first
described as a potent transcriptional repressor (Nan, 1998).
Mutations in MeCP2 cause Rett syndrome, mental retardation,
Angelman syndrome, and autism (Hite et al., 2009; Gonzales
and LaSalle, 2010). The up-regulation of MeCP2 via microRNAs
corroborated the general gene-repression in tolerance reported
before (Lusardi et al., 2010), as increase levels of MeCP2 resulted
in a down-regulation of the transcriptome.
In contrast to these studies, Lee et al. showed that neuro-
protection achieved by brief ischemic preconditioning stimuli in
mice could be due to a family member of miR-200 which targets
PHD2 (prolyl hydroxylate 2), which in turn has been involved
in the regulation of HIF1α after ischemia (Lee et al., 2010). Up-
regulation of miR-200 shortly after the preconditioning stimulus
reduced the levels of PHD2 and increased HIF1α. These results
were corroborated in vitro, where the up-regulation of miR-200
using mimic decreased levels of PHD2 (Lee et al., 2010). Sup-
porting these results, transgenic mice lacking HIF1α exposed
to hypoxic preconditioning presented less neuroprotection than
control mice after an hypoxia-ischemic insult (Sheldon et al.,
2014).
TABLE 1 | MicroRNAs in preconditioning.
Preconditioning
stimulus
microRNAs Target gene References
Ischemia Pull ofmiRs MeCP2 Lusardi et al., 2010
Ischemia miR-200 PhP2 Lee et al., 2010
Hybernation miR-200 SUMO Lee et al., 2012
Epileptic miR-184 Not determined McKiernan et al., 2012
More recently, a model of hibernation, a natural model of tol-
erance to ischemia, was used to study the role of microRNAs
during neuroprotection in the brain (Lee et al., 2012). During
torpor stages, hibernating animals lower their energy consump-
tion, blood flow, and body temperature to an otherwise lethal
level which is similar to levels during an ischemic insult (Lee
et al., 2012). Microarray analysis from ground squirrel brains
were performed during the active and the torpor phase and 405
microRNAs were different between both stages, with the family
of miR-200 being the most representative, consistent with Lee
et al. (2010). In this study the authors suggest that miR-200 family
could regulate members of the SUMO family which is involved
in the ubiquitin regulation and protein degradation, thereby
explaining the reduction in protein levels during tolerance (Lee
et al., 2012).
microRNA in Epileptic Preconditioning
Similar to ischemia, several studies analyzed the role of
microRNAs after a preconditioning-seizure stimuli (Table 1 and
Hatazaki et al., 2007; Kretschmann et al., 2015).
McKiernan and colleagues by using low dose of systemic KA
in mice showed a de-regulation of microRNA after epileptic pre-
conditioning. Here, a general up-regulation of microRNAs was
the main response in preconditioned mice compared to con-
trol mice (McKiernan et al., 2012). Whereas 9 microRNAs were
uniquely present in the preconditioning group, 39 microRNAs
showed increase and 6 reduced levels in the pre-conditioning
group. From the up-regulated microRNAs, 25 of the 39 were
significantly regulated (McKiernan et al., 2012). Between the up-
regulated microRNA group, the highest levels were found for
miR-184. Inhibition of miR-184 in vivo resulted in neuronal
death after a normally non-damaging preconditional stimulus
(McKiernan et al., 2012) and an increase in neurodegeneration
during the tolerant state after status epilepticus (damaging injury
stimulation). Together, these results show a neuroprotective role
of miR-184 during preconditioning (McKiernan et al., 2012).
Similar results have been found in acute seizure models
not associated with neuronal death (Kretschmann et al., 2015).
Kretschman and colleagues showed that 6 h after the induction
of a single seizure via electrical stimulation up-regulation of
microRNAs was the main response. 146 microRNAs were de-
regulated, with almost 140 microRNAs being up-regulated and
only few of them down-regulated (Kretschmann et al., 2015).
In a more detailed study, the expression levels of microR-
NAs were analyzed after electroshock stimulation, showing that
microRNA levels follow three distinct patterns after non-damage
neuronal activity (Eacker et al., 2011). MicroRNA regulation
can be clustered in three distinct groups: Class 1, microRNAs
which progressively increase their expression levels after electri-
cal stimulation, including miR-134; Class 2, microRNAs which
are strongly up-regulated in the first hours after stimulation with
levels decreasing back to normal rapidly; Class 3, microRNAs that
increase initially but decrease at a later time-point (12 or 24 h
after the stimulation) (Eacker et al., 2011). This study shows the
specific response of microRNAs after brain stimulation, and its
possible role in the different tolerant-stages.
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Targeting microRNAs on Brain
Several approaches for manipulating miRNA levels in neuronal
cells in vitro and in vivo have been described, including recent
applications of miRNA antisense oligonucleotides, miRNA gene
knockout andmiRNA sponges in neuronal cells. The efficiency of
microRNAs inhibitors has been reported several times, inhibition
of miR184 show a loss in the preconditioning neuroprotection
without any toxicity (McKiernan et al., 2012). In contrast, no
many approaches have shown over-expression of microRNAs in
the brain, possible related with the toxic effect increase levels of
RNA in the brain. The study of new drugs which target microR-
NAs in the central nervous system will be one of the main fields
of future investigations.
Conclusions
Studying the molecular mechanism underlying the innate
neuroprotection can help to understand how the brain pro-
tects itself against a damaging insult. Analysis of tolerant states
has shown that a general down-regulation of genes is the main
response in the brain, independently of the original insult,
ischemic, or seizures. MicroRNAs are master regulators of
gene-expression, its regulation after the preconditioning stim-
ulus could be causative of the general suppression of gene-
expression and being a good candidate for future target-therapy.
Still several questions are remaining: Can we regulate microR-
NAs in the brain? Systemic administration of microRNA mim-
ics or microRNA inhibitors will be necessary. Can we regulate
microRNA expression in a time dependent manner? Tolerant is
a time-dependent effect which only last for several days, a longer
inhibition or over-expression of microRNAs could be toxic for
the brain.
Acknowledgments
The author would like to thank Dr. Tobias Engel and Prof. David
C. Henshall for critical reading of the manuscript. This work
was supported by grants from the Science Foundation Ireland
(13/SIRG/2114) to EJ.
References
Amini, E., Rezaei,M.,Mohamed Ibrahim, N., Golpich,M., Ghasemi, R.,Mohamed,
Z., et al. (2014). A molecular approach to epilepsy management: from cur-
rent therapeutic methods to preconditioning efforts. Mol. Neurobiol. doi:
10.1007/s12035-014-8876-5. [Epub ahead of print].
Assaf, F., Fishbein, M., Gafni, M., Keren, O., and Sarne, Y. (2011). Pre- and post-
conditioning treatment with an ultra-low dose of Delta9-tetrahydrocannabinol
(THC) protects against pentylenetetrazole (PTZ)-induced cognitive damage.
Behav. Brain Res. 220, 194–201. doi: 10.1016/j.bbr.2011.02.005
Babiarz, J. E., Hsu, R., Melton, C., Thomas, M., Ullian, E. M., and Blelloch, R.
(2011). A role for noncanonical microRNAs in the mammalian brain revealed
by phenotypic differences in Dgcr8 versus Dicer1 knockouts and small RNA
sequencing. RNA 17, 1489–1501. doi: 10.1261/rna.2442211
Barone, F. C., White, R. F., Spera, P. A., Ellison, J., Currie, R. W., Wang, X.,
et al. (1998). Ischemic preconditioning and brain tolerance: temporal histolog-
ical and functional outcomes, protein synthesis requirement, and interleukin-1
receptor antagonist and early gene expression. Stroke 29, 1937–1950. discus-
sion: 1950–1931. doi: 10.1161/01.STR.29.9.1937
Baskerville, S., and Bartel, D. P. (2005). Microarray profiling of microRNAs reveals
frequent coexpression with neighboring miRNAs and host genes. RNA 11,
241–247. doi: 10.1261/rna.7240905
Bicker, S., Khudayberdiev, S., Weiß, K., Zocher, K., Baumeister, S., and Schratt,
G. (2013). The DEAH-box helicase DHX36 mediates dendritic localiza-
tion of the neuronal precursor-microRNA-134. Genes Dev. 27, 991–996. doi:
10.1101/gad.211243.112
Bohnsack, M. T., Czaplinski, K., and Gorlich, D. (2004). Exportin 5 is a
RanGTP-dependent dsRNA-binding protein that mediates nuclear export of
pre-miRNAs. RNA 10, 185–191. doi: 10.1261/rna.5167604
Borges, K., Shaw, R., and Dingledine, R. (2007). Gene expression changes after
seizure preconditioning in the three major hippocampal cell layers. Neurobiol.
Dis. 26, 66–77. doi: 10.1016/j.nbd.2006.12.001
Burroughs, A. M., Ando, Y., de Hoon, M. J., Tomaru, Y., Suzuki, H., Hayashizaki,
Y., et al. (2011). Deep-sequencing of human Argonaute-associated small
RNAs provides insight into miRNA sorting and reveals Argonaute associ-
ation with RNA fragments of diverse origin. RNA Biol. 8, 158–177. doi:
10.4161/rna.8.1.14300
Cai, X., Hagedorn, C. H., and Cullen, B. R. (2004). Human microRNAs are
processed from capped, polyadenylated transcripts that can also function as
mRNAs. RNA 10, 1957–1966. doi: 10.1126/science.1102513
Chen, J., and Simon, R. (1997). Ischemic tolerance in the brain. Neurology 48,
306–311. doi: 10.1212/WNL.48.2.306
Czech, B., and Hannon, G. J. (2011). Small RNA sorting: matchmaking for
Argonautes. Nat. Rev. Genet. 12, 19–31. doi: 10.1038/nrg2916
Davis, T. H., Cuellar, T. L., Koch, S. M., Barker, A. J., Harfe, B. D., McManus, M.
T., et al. (2008). Conditional loss of Dicer disrupts cellular and tissue mor-
phogenesis in the cortex and hippocampus. J. Neurosci. 28, 4322–4330. doi:
10.1523/JNEUROSCI.4815-07.2008
Della-Morte, D., Guadagni, F., Palmirotta, R., Ferroni, P., Testa, G., Cacciatore,
F., et al. (2012). Genetics and genomics of ischemic tolerance: focus on cardiac
and cerebral ischemic preconditioning. Pharmacogenomics 13, 1741–1757. doi:
10.2217/pgs.12.157
De Pietri Tonelli, D., Pulvers, J. N., Haffner, C., Murchison, E. P., Hannon, G. J.,
andHuttner,W. B. (2008). miRNAs are essential for survival and differentiation
of newborn neurons but not for expansion of neural progenitors during early
neurogenesis in themouse embryonic neocortex.Development 135, 3911–3921.
doi: 10.1242/dev.025080
Dharap, A., and Vemuganti, R. (2010). Ischemic pre-conditioning alters cere-
bral microRNAs that are upstream to neuroprotective signaling pathways.
J. Neurochem. 113, 1685–1691. doi: 10.1111/j.1471-4159.2010.06735.x
Dirnagl, U., Becker, K., and Meisel, A. (2009). Preconditioning and tolerance
against cerebral ischaemia: from experimental strategies to clinical use. Lancet
Neurol. 8, 398–412. doi: 10.1016/S1474-4422(09)70054-7
Dorval, V., Smith, P. Y., Delay, C., Calvo, E., Planel, E., Zommer, N., et al.
(2012). Gene network and pathway analysis of mice with conditional abla-
tion of Dicer in post-mitotic neurons. PLoS ONE 7:e44060. doi: 10.1371/jour-
nal.pone.0044060
Eacker, S. M., Keuss, M. J., Berezikov, E., Dawson, V. L., and Dawson, T. M.
(2011). Neuronal activity regulates hippocampal miRNA expression. PLoS ONE
6:e25068. doi: 10.1371/journal.pone.0025068
Gonzales, M. L., and LaSalle, J. M. (2010). The role of MeCP2 in brain develop-
ment and neurodevelopmental disorders. Curr. Psychiatry Rep. 12, 127–134.
doi: 10.1007/s11920-010-0097-7
Hatazaki, S., Bellver-Estelles, C., Jimenez-Mateos, E. M., Meller, R., Bonner, C.,
Murphy, N., et al. (2007). Microarray profile of seizure damage-refractory hip-
pocampal CA3 in a mouse model of epileptic preconditioning. Neuroscience
150, 467–477. doi: 10.1016/j.neuroscience.2007.09.020
Hite, K. C., Adams, V. H., and Hansen, J. C. (2009). Recent advances in
MeCP2 structure and function. Biochem. Cell Biol. 87, 219–227. doi: 10.1139/
O08-115
Hsu, R., Schofield, C. M., Dela Cruz, C. G., Jones-Davis, D. M., Blelloch, R., and
Ullian, E. M. (2012). Loss of microRNAs in pyramidal neurons leads to specific
changes in inhibitory synaptic transmission in the prefrontal cortex.Mol. Cell.
Neurosci. 50, 283–292. doi: 10.1016/j.mcn.2012.06.002
Frontiers in Neuroscience | www.frontiersin.org 4 April 2015 | Volume 9 | Article 118
Jimenez-Mateos microRNAs in brain preconditioning
Jimenez-Mateos, E. M., Hatazaki, S., Johnson, M. B., Bellver-Estelles, C., Mouri,
G., Bonner, C., et al. (2008). Hippocampal transcriptome after status epilep-
ticus in mice rendered seizure damage-tolerant by epileptic preconditioning
features suppressed calcium and neuronal excitability pathways.Neurobiol. Dis.
32, 442–453. doi: 10.1016/j.nbd.2008.08.008
Kitagawa, K.,Matsumoto,M., Kuwabara, K., Tagaya,M., Ohtsuki, T., Hata, R., et al.
(1990). “Ischemic tolerance” phenomenon found in the brain. Brain Res. 528,
21–24. doi: 10.1016/0006-8993(90)90189-I
Klein, M. E., Lioy, D. T., Ma, L., Impey, S., Mandel, G., and Goodman, R. H. (2007).
Homeostatic regulation of MeCP2 expression by a CREB-induced microRNA.
Nat. Neurosci. 10, 1513–1514. doi: 10.1038/nn2010
Knuckles, P., Vogt, M. A., Lugert, S., Milo, M., Chong, M. M., Hautbergue, G.
M., et al. (2012). Drosha regulates neurogenesis by controlling neurogenin
2 expression independent of microRNAs. Nat. Neurosci. 15, 962–969. doi:
10.1038/nn.3139
Kobayashi, S., Harris, V. A., andWelsh, F. A. (1995). Spreading depression induces
tolerance of cortical neurons to ischemia in rat brain. J. Cereb. Blood Flow
Metab. 15, 721–727. doi: 10.1038/jcbfm.1995.92
Konopka, W., Kiryk, A., Novak, M., Herwerth, M., Parkitna, J. R., Wawrzyniak,
M., et al. (2010). MicroRNA loss enhances learning and memory in mice.
J. Neurosci. 30, 14835–14842. doi: 10.1523/JNEUROSCI.3030-10.2010
Kretschmann, A., Danis, B., Andonovic, L., Abnaof, K., van Rikxoort, M., Siegel,
F. et al. (2015). Different microRNA profiles in chronic epilepsy versus acute
seizure mouse models. J. Mol. Neurosci. 55, 466–479. doi: 10.1007/s12031-014-
0368-6
Kwak, P. B., and Tomari, Y. (2012). The N domain of Argonaute drives duplex
unwinding during RISC assembly. Nat. Struct. Mol. Biol. 19, 145–151. doi:
10.1038/nsmb.2232
Lagos-Quintana, M., Rauhut, R., Lendeckel, W., and Tuschl, T. (2001). Identifica-
tion of novel genes coding for small expressed RNAs. Science 294, 853–858. doi:
10.1126/science.1064921
Lugli, G. I., Larson, J., Martone,M. E., Jones, Y., and Smalheiser, N. R. (2005). Dicer
and eIF2c are enriched at postsynaptic densities in adult mouse brain and are
modified by neuronal activity in a calpain-dependent manner. J. Neurochem.
94, 896–905. doi: 10.1111/j.1471-4159.2005.03224.x
Lau, N. C., Lim, L. P., Weinstein, E. G., and Bartel, D. P. (2001). An abundant class
of tiny RNAs with probable regulatory roles in Caenorhabditis elegans. Science
294, 858–862. doi: 10.1126/science.1065062
Lee, R. C., and Ambros, V. (2001). An extensive class of small RNAs in Caenorhab-
ditis elegans. Science 294, 862–864. doi: 10.1126/science.1065329
Lee, S. T., Chu, K., Jung, K. H., Yoon, H. J., Jeon, D., Kang, K. M., et al. (2010).
MicroRNAs induced during ischemic preconditioning. Stroke 41, 1646–1651.
doi: 10.1161/STROKEAHA.110.579649
Lee, Y., Ahn, C., Han, J., Choi, H., Kim, J., Yim, J., et al. (2003). The nuclear
RNase III Drosha initiates microRNA processing. Nature 425, 415–419. doi:
10.1038/nature01957
Lee, Y. J., Johnson, K. R., and Hallenbeck, J. M. (2012). Global protein con-
jugation by ubiquitin-like-modifiers during ischemic stress is regulated by
microRNAs and confers robust tolerance to ischemia. PLoS ONE 7:e47787. doi:
10.1371/journal.pone.0047787
Lee, Y., Kim, M., Han, J., Yeom, K. H., Lee, S., Baek, S. H., et al. (2004). MicroRNA
genes are transcribed by RNA polymerase II. EMBO J. 23, 4051–4060. doi:
10.1038/sj.emboj.7600385
Lin, J. H., Lou, N., Kang, N., Takano, T., Hu, F., Han, X., et al. (2008). A central
role of connexin 43 in hypoxic preconditioning. J. Neurosci. 28, 681–695. doi:
10.1523/JNEUROSCI.3827-07.2008
Liu, J., Carmell, M. A., Rivas, F. V., Marsden, C. G., Thomson, J. M., Song, J. J.,
et al. (2004). Argonaute2 is the catalytic engine of mammalian RNAi. Science
305, 1437–1441. doi: 10.1126/science.1102513
Lugli, G., Torvik, V. I., Larson, J., and Smalheiser, N. R. (2008). Expression of
microRNAs and their precursors in synaptic fractions of adult mouse forebrain.
J. Neurochem. 106, 650–661. doi: 10.1111/j.1471-4159.2008.05413.x
Lusardi, T. A., Farr, C. D., Faulkner, C. L., Pignataro, G., Yang, T., Lan, J., et al.
(2010). Ischemic preconditioning regulates expression of microRNAs and a
predicted target, MeCP2, in mouse cortex. J. Cereb. Blood Flow Metab. 30,
744–756. doi: 10.1038/jcbfm.2009.253
McCafferty, K., Forbes, S., Thiemermann, C., and Yaqoob, M. M. (2014).
The challenge of translating ischemic conditioning from animal models to
humans: the role of comorbidities. Dis. Model. Mech. 7, 1321–1333. doi:
10.1242/dmm.016741
McKiernan, R. C., Jimenez-Mateos, E. M., Sano, T., Bray, I., Stallings, R. L., Simon,
R. P., et al. (2012). Expression profiling the microRNA response to epileptic
preconditioning identifies miR-184 as a modulator of seizure-induced neuronal
death. Exp. Neurol. 237, 346–354. doi: 10.1016/j.expneurol.2012.06.029
Meller, R., Thompson, S. J., Lusardi, T. A., Ordonez, A. N., Ashley, M. D., Jes-
sick, V., et al. (2008). Ubiquitin proteasome-mediated synaptic reorganization:
a novel mechanism underlying rapid ischemic tolerance. J. Neurosci. 28, 50–59.
doi: 10.1523/JNEUROSCI.3474-07.2008
Mirrione, M. M., Konomos, D. K., Gravanis, I., Dewey, S. L., Aguzzi, A., Heppner,
F. L., et al. (2010). Microglial ablation and lipopolysaccharide precondition-
ing affects pilocarpine-induced seizures in mice. Neurobiol. Dis. 39, 85–97. doi:
10.1016/j.nbd.2010.04.001
Morita, S., Horii, T., Kimura, M., Goto, Y., Ochiya, T., and Hatada, I. (2007). One
Argonaute family member, Eif2c2 (Ago2), is essential for development and
appears not to be involved in DNA methylation. Genomics 89, 687–696. doi:
10.1016/j.ygeno.2007.01.004
Murry, C. E., Jennings, R. B., and Reimer, K. A. (1986). Preconditioning with
ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 74,
1124–1136. doi: 10.1161/01.CIR.74.5.1124
Nan, X. (1998). Gene silencing by methyl-CpG-binding proteins. Novartis Found.
Symp. 214, 6–16. discussion: 16–21, 46–50.
O’Carroll, D., Mecklenbrauker, I., Das, P. P., Santana, A., Koenig, U., Enright, A.
J., et al. (2007). A Slicer-independent role for Argonaute 2 in hematopoiesis and
the microRNA pathway. Genes Dev. 21, 1999–2004. doi: 10.1101/gad.1565607
O’Carroll, D., and Schaefer, A. (2013). General principals of miRNA biogen-
esis and regulation in the brain. Neuropsychopharmacology 38, 39–54. doi:
10.1038/npp.2012.87
Plamondon, H., Blondeau, N., Heurteaux, C., and Lazdunski, M. (1999). Mutu-
ally protective actions of kainic acid epileptic preconditioning and sublethal
global ischemia on hippocampal neuronal death: involvement of adenosine A1
receptors and K(ATP) channels. J. Cereb. Blood FlowMetab. 19, 1296–1308. doi:
10.1097/00004647-199912000-00002
Sheldon, R. A., Lee, C. L., Jiang, X., Knox, R. N., and Ferriero, D. M. (2014).
Hypoxic preconditioning protection is eliminated in HIF-1alpha knockout
mice subjected to neonatal hypoxia-ischemia. Pediatr. Res. 76, 46–53. doi:
10.1038/pr.2014.53
Siegel, G., Saba, R., and Schratt, G. (2011). microRNAs in neurons: manifold
regulatory roles at the synapse. Curr. Opin. Genet. Dev. 21, 491–497. doi:
10.1016/j.gde.2011.04.008
Simon, R. P., Niiro, M., and Gwinn, R. (1993). Prior ischemic stress protects
against experimental stroke. Neurosci. Lett. 163, 135–137. doi: 10.1016/0304-
3940(93)90364-Q
Stenzel-Poore, M. P., Stevens, S. L., King, J. S., and Simon, R. P. (2007). Precondi-
tioning reprograms the response to ischemic injury and primes the emergence
of unique endogenous neuroprotective phenotypes: a speculative synthesis.
Stroke 38, 680–685. doi: 10.1161/01.STR.0000251444.56487.4c
Stenzel-Poore, M. P., Stevens, S. L., and Simon, R. P. (2004). Genomics
of preconditioning. Stroke 35(11 Suppl. 1), 2683–2686. doi:
10.1161/01.STR.0000143735.89281.bb
Tao, J., Wu, H., Lin, Q., Wei, W., Lu, X. H., Cantle, J. P., et al. (2011). Deletion of
astroglial Dicer causes non-cell-autonomous neuronal dysfunction and degen-
eration. J. Neurosci. 31, 8306–8319. doi: 10.1523/JNEUROSCI.0567-11.2011
Towfighi, J., Housman, C., Mauger, D., and Vannucci, R. C. (1999). Effect of
seizures on cerebral hypoxic-ischemic lesions in immature rats. Brain Res. Dev.
Brain Res. 113, 83–95. doi: 10.1016/S0165-3806(99)00004-8
Conflict of Interest Statement: The author declares that the research was con-
ducted in the absence of any commercial or financial relationships that could be
construed as a potential conflict of interest.
Copyright © 2015 Jimenez-Mateos. This is an open-access article distributed under
the terms of the Creative Commons Attribution License (CC BY). The use, distribu-
tion or reproduction in other forums is permitted, provided the original author(s)
or licensor are credited and that the original publication in this journal is cited, in
accordance with accepted academic practice. No use, distribution or reproduction is
permitted which does not comply with these terms.
Frontiers in Neuroscience | www.frontiersin.org 5 April 2015 | Volume 9 | Article 118
